TY  - CONF

T1  - Intravitreal therapy with Ranibizumab vs Aflibercept vs Bevacizumab for macular oedema due to central retinal vein occlusion : a within trial cost-utility analysis

JO  - Value in Health

UR  - http://eprints.whiterose.ac.uk/155211/

PY  - 2019/11/01

AU  - Flight L

AU  - Alshreef A

AU  - Hykin PG

AU  - Sivaprasad S

AU  - Pennington B

AU  - Kelly J

AU  - Murphy CL

AU  - Brazier JE

ED  - 

DO  - DOI: 10.1016/j.jval.2019.09.1396

PB  - Elsevier

VL  - 22

IS  - Suppl 3

SP  - S664

EP  - S664

Y2  - 2024/12/25

ER  -